Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 151,077
- Estimated value
- $67,985
- Report date
- 23 Dec 2024
- Price
- $0.4500
- Ownership
- Direct
Gordon Dunn - Chief Financial Officer at Quoin Pharmaceuticals, Ltd.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- QNRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Gordon Dunn since 11 Sep 2025
Reported holdings for Gordon Dunn in Quoin Pharmaceuticals, Ltd.
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 338,994
- Estimated value
- Report date
- 09 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Series F Warrants (right to buy)
- Shares / value
- 122,221
- Estimated value
- Report date
- 23 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Form 4 holding
Chief Financial Officer
Quoin Pharmaceuticals, Ltd.
- Security class
- Series G Warrants (right to buy)
- Shares / value
- 122,221
- Estimated value
- Report date
- 23 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- ADS
- Underlying amount
Transaction history for Gordon Dunn in Quoin Pharmaceuticals, Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.